All In Biotech

Drug Trial Radar · NCT06958211

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 573 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

573

Actual

Start

Jun 12, 2025

Primary completion

Oct 1, 2026

Study completion Jul 11, 2027

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
May 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.

Conditions

  • Hidradenitis Suppurativa

Interventions

  • Ruxolitinib CreamDrug

    Ruxolitinib cream applied topically to the affected area as a thin film twice daily.

  • Vehicle CreamDrug

    Matching vehicle cream applied topically to the affected area as a thin film twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants who achieve Hidradenitis Suppurativa (HS) Clinical Response 75 (HiSCR75) from baselineTime frame: Week 16

Locations

107 sites in 9 countries. Site status is shown where the registry gives one.

  • Investigative Site US257

    Birmingham, Alabama

  • Investigative Site US218

    Birmingham, Alabama

  • Investigative Site US239

    Montgomery, Alabama

  • Investigative Site US215

    Phoenix, Arizona

  • Investigative Site US261

    Phoenix, Arizona

  • Investigative Site US240

    Tucson, Arizona

  • Investigative Site US262

    Encino, California

  • Investigative Site US222

    Fountain Valley, California

  • Investigative Site US211

    Los Angeles, California

  • Investigative Site US237

    Los Angeles, California

  • Investigative Site US234

    Northridge, California

  • Investigative Site US250

    Santa Ana, California

  • Investigative Site US244

    Castle Rock, Colorado

  • Investigative Site US252

    Cromwell, Connecticut

  • Investigative Site US208

    Boca Raton, Florida

  • Investigative Site US203

    Hialeah, Florida

  • Investigative Site US258

    Jacksonville, Florida

  • Investigative Site US206

    Maitland, Florida

  • Investigative Site US223

    Miami, Florida

  • Investigative Site US241

    Miami, Florida

  • Investigative Site US202

    Miami, Florida

  • Investigative Site US214

    Tampa, Florida

  • Investigative Site US247

    Tampa, Florida

  • Investigative Site US231

    Columbus, Georgia

  • Investigative Site US225

    Sandy Springs, Georgia

  • Investigative Site US207

    Skokie, Illinois

  • Investigative Site US205

    Plainfield, Indiana

  • Investigative Site US264

    Lake Charles, Louisiana

  • Investigative Site US266

    New Orleans, Louisiana

  • Investigative Site US254

    Gambrills, Maryland

  • Investigative Site US201

    Marriottsville, Maryland

  • Investigative Site US253

    Milford, Massachusetts

  • Investigative Site US227

    Needham, Massachusetts

  • Investigative Site US268

    Worcester, Massachusetts

  • Investigative Site US238

    Ann Arbor, Michigan

  • Investigative Site US230

    Auburn Hills, Michigan

  • Investigative Site US251

    St Louis, Missouri

  • Investigative Site US271

    Wildwood, Missouri

  • Investigative Site US212

    Missoula, Montana

  • Investigative Site US216

    Las Vegas, Nevada

Showing 40 of 107 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.